Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solace Lifesciences is a private U.S. neuroscience and health technology company best known for NuCalm, a commercial stress-management and sleep-improvement system. The company markets a patented, non-drug platform that combines neuroacoustic software, biosignal processing components, and sensory modulation to shift users toward a parasympathetic, relaxation-oriented state. Its business appears focused on consumer wellness, performance, recovery, and use in settings such as dentistry, public safety, and supportive care rather than on developing prescription therapeutics. Solace Lifesciences positions itself as a neuroscience innovator addressing chronic stress and autonomic nervous system balance, with NuCalm serving as its flagship and effectively sole named product platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solace Lifesciences.